The Microbiology Independent Research Journal (MIR Journal) is a new international resource for academic researchers and professionals in the pharmaceutical and biopharmaceutical industry. MIR Journal publishes strictly peer-reviewed papers that cover novel aspects in microbiology including virology, bacteriology, and mycology.
The main objective of the MIR Journal is to provide broad international coverage of scientific results in microbiology and to extend the accessibility of the journal’s content. In order to meet this goal, all of the papers are published in the English language and available in open access format online.
Microorganisms such as bacteria, viruses, fungi or parasites can spread between individuals and cause the infectious diseases. Some of these diseases are very dangerous and can be life threatening (avian influenza, Ebola and Zika viral infections, malaria, tuberculosis, tetanus et al.). Intensive epidemiological monitoring is one of the basic measures necessary for their control. Infectious agents do not recognize country borders, and that’s why close worldwide cooperation between scientists and medical personnel is necessary in order to prevent the spread of dangerous pathogens. No single country can deal with this global threat alone. In order to solve this problem, it is necessary to ensure that the results of the research obtained by scientists of any country are easily accessible to the whole scientific community.
Therefore, all submitted articles are peer-reviewed and, upon acceptance, are published in English on the MIR Journal website in open access format – free of charge for the readers. Quick, easy, and convenient access to the full text of articles makes the information about occurrence, properties, and distribution of the known and newly emerging infectious agents available immediately to the scientific community and practicing medical personnel.
For more information read the article Why do we need a new open access journal devoted to microbiology?
MIR journal is published annually and online only. The final versions of accepted papers are published online immediately. Each paper is assigned a Digital Object Identifier (DOI).
MIR Journal requires that authors follow the International Committee of Medical Journal Editors (ICMJE) recommendations on the Conduct, Reporting, Editing, and Publication of Scholarly articles in Medical Journals. More information can be found at http://www.icmje.org
MIR Journal upholds the following publication policy:
Policy for submitted paper version: open access is not allowed.
Policy for accepted paper version: open access is not allowed.
Policy for published paper version: open access is allowed.
The published paper version can be deposited in: Institutional Repository, Pre-Print Server, Author’s Personal Website, or any other Open Access repositories. There is no embargo for the distribution of the published paper version.
MIR journal publishes the following categories of scientific papers
Fully comprehensive in its scope, MIR Journal highlights important discoveries in all aspects of microbiology, including virology, bacteriology, and mycology.
In particular, the journal publishes articles devoted to
Special attention is paid to new antiviral or antimicrobial drugs, development, and evaluation of vaccines, immune response to vaccines in humans and animals, new approaches to development of vaccines, new vaccine vectors, and clinical trial results for new vaccines and new drugs (Phases I through III).
MIR Journal provides open access to all of the published papers from the first day of publishing. All journal expenses are recovered by charging a publication fee. Authors submitting a publication are required to pay the fee of 500 euros. Papers written by Ph.D. students are published free of charge.
However, if the research was not adequately financially supported, the MIR Journal Financial department can consider the request to reduce the publication price (please contact firstname.lastname@example.org). The decision will be based on the scientific significance of the submitted paper.
MIR Journal accepts manuscripts in the English and Russian languages. For articles written in English, only a US English version will be published after the peer-review process. The Abstract will be translated into Russian and published on the Journal’s website. In addition, if the manuscript is submitted in English, the authors are offered a proofreading service by English native speakers. To request proofreading, please contact us at email@example.com.
Articles written in Russian will be reviewed and, upon acceptance, translated by experts in the field to English. Both versions (Russian and English) will be published online. The expenses for the translation of Russian articles into English are covered by the publication fee.
Two independent external reviewers consider each article submitted to the editorial board. If they have different recommendations on acceptance of the manuscript, the manuscript is sent to an additional reviewer. An article is considered accepted for publication if it has received at least two positive reviews. The names of the reviewers are not disclosed to the authors.
MIR Journal is committed to ensuring that the authors’ privacy is protected. The authors can be assured that all the private information that is provided to the editorial board will not be shared with any third parties.
If an error in the publication is found, MIR Journal will publish a correction notice as soon as possible detailing the changes and citing the original publication. The reference to the correction notice will be included in an electronic Table of Contents to ensure proper indexing. The new article version will be posted with details of the changes from the original version and the date(s) on which the changes were made.
When scientific misconduct is alleged, or concerns are raised about the conduct or integrity of work described in submitted or published papers, appropriate procedures in order to investigate and prove scientific misconduct will be initiated. In case of a positive investigation outcome, MIR Journal will publish a retraction of the article. The retracted article will be clearly labeled as retracted in all its forms (abstract, full text, PDF).
MIR Journal operates according to the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License (CC BY-NC-SA license), which can be found at http://creativecommons.org/licenses/by-nc-sa/3.0/deed.en. According to this license, the authors keep the copyright for the contents of the Article, but anyone, hereinafter referred as the “Licensee”, has the right to download, reuse, reprint, translate to a different language, copy, and/or distribute the contents of the Article as long as the material is not used for commercial purposes provided that a new publication will have a reference to the authors of the original Article and the journal that the original Article was first published in, and that this publication will have the corresponding licensing. This license also gives the right for the Licensee to edit, change, or build on the text of the original Article and publish this material provided that a new publication will have a reference on the authors of the original Article and the journal that the original Article was first published in, and that this publication will have the corresponding licensing. If the Publisher does not like how the material has been modified or used, CC BY-NC-SA license requires that the Licensee removes the attribution information upon the Publisher’s request.
The appropriate attribution can be provided by presenting the reference to the original paper, e.g., Egorov AY. The challenges of creating a universal influenza vaccine. MIR J 2016, 3 (1), 31-41 DOI: 10.18527/2500-2236-2016-3-1-31-41.
All the participants in the journal publication process - authors, peer reviewers, editors, and editorial board members must consider their conflicts of interest when fulfilling their roles in the process of article review and publication and must disclose all the relationships that could be viewed as potential conflicts of interest.
In case the Editor-in-Chief, Associate Editor, or Editorial Board member submits a paper to MIR Journal, another Editor is responsible for making the editorial decision.
When authors submit a manuscript to MIR Journal, they are responsible for disclosing all financial and personal relationships that might bias or be seen to bias their work. The corresponding author should sign Form for Disclosure of Conflicts of Interest developed by ICMJE, which can be found at www.icmje.org/coi_disclosure.pdf
MIR Journal Regulations on Publication Ethics were developed in accordance with the recommendations of COPE's (Committee on Publication Ethics) Best Practice Guidelines available at https://publicationethics.org/about
1. Duties of the Editor-in-Chief and Editorial Board
1.1. Decision about the publication of manuscript
Editor-in-Chief and Editorial Board of the MIR Journal make decisions to accept or reject the manuscripts for publication based solely on the content and scientific value of the submitted manuscript.
Editor and all the members of Editorial Board should treat all the information related to the submitted manuscripts as strictly confidential.
1.3. Conflicts of interest
Editor-in-Chief and the members of Editorial Board should not use information from the submitted manuscripts in their personal interests. The Editorial Board should reveal any possible conflicts of interest.
1.4. Complaints handling
The Editor-in-Chief and members of Editorial Board should resolve all the conflicts, complaints, or claims arising in connection with the submitted manuscript according to the COPE's recommendations.
2. The Duties of reviewers
2.1. Decision about the publication of the manuscript
The reviewer should make an expert assessment of the manuscript solely on the basis of its content and should express a recommendation for or against acceptance of the manuscript for publication. The reviewer can also provide suggestions on improving the manuscript. Personal criticism of the author is not acceptable.
2.2. The terms of manuscript review
The reviewer, who agreed to review the manuscript, should comply with the time frame set by the editorial office for writing the review of the manuscript. Reviewers who cannot meet the deadline for the reviewing of the manuscript should notify the editorial office.
Reviewers should keep all the information concerning the manuscript in confidence. It is unacceptable to discuss the manuscript with the third parties without the consent of the editor.
2.4. Proof of novelty
The reviewer should verify the originality of the conducted research, the correctness of the given conclusions, adequacy (or accordance) of the references, and identify similar publications.
2.5. Conflicting parties
Any and all information that becomes available for the reviewer in the course of the manuscript reviewing should not be used for their self-profit. The reviewer should inform the MIR Journal editorial office about any conflicts of interest. The reviewer should not consider for review the manuscripts of authors if the reviewer has a competitive position on the subject of research, described in the manuscript.
3. Author's duties
Authors should guarantee that the submitted manuscripts describe the results of their own original research. If the submitted manuscript describes the continuation of a research project, the references to the previous studies on this topic should be presented.
3.2 Access to the data
The authors of the manuscript should cite all the data sources, which they used while they were writing the manuscript. The authors should be ready to present the original data supporting the results published in their manuscript to editorial office for review.
3.3. Originality and plagiarism
The authors should guarantee that the research described in the manuscript is original, and that the manuscript was not published earlier in a different journal (elsewhere). Plagiarism in any form is not acceptable.